Integer to Showcase Innovations in Neuromodulation, Miniaturized Active Implantable Device Technology During NANS 2026 Annual Meeting

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the medical device sector, will showcase its innovations in neuromodulation and miniaturized active implantable devices (AIMDs) at the upcoming North American Neuromodulation Society (NANS) Annual Meeting, taking place in Las Vegas from January 22-25, 2026. Visitors to Integer’s booth (#115) can expect to see cutting-edge advancements designed to enhance the development timeline and minimize risks for medical device companies introducing groundbreaking therapies.

Jim Stephens, President of Cardiac Rhythm Management & Neuromodulation at Integer, emphasizes the transformative impact of miniaturization on the future of implantable technologies. The company’s extensive expertise encompasses every essential component, from high-performance batteries to fully integrated implantable pulse generators and lead systems, all geared toward empowering customer innovations in the field of neuromodulation.

A highlight of Integer's exhibit will be the Xcellion® Gen 3 Fast Charge Lithium Ion battery technology. This state-of-the-art battery is designed for superior runtime and can be recharged in as little as 30 minutes, making it a game-changer for medical device functionality and patient convenience.

Integer Holdings Corporation stands as one of the largest medical device contract development and manufacturing organizations globally. With a commitment to enhancing patient lives through innovative, high-quality solutions in the cardiac rhythm management and neuromodulation spheres, Integer partners with medical device companies and OEMs to push the boundaries of medical technology. Attendees are encouraged to visit booth #115 to learn more about Integer’s technologies and how they can support the next wave of medical advancements. For further information, interested parties can explore Integer's offerings at www.integer.net.

Integer Holdings Corporation (NYSE: ITGR) is positioning itself as a leader in the burgeoning field of neuromodulation and miniaturized active implantable device technology. As the company prepares for its participation in the upcoming North American Neuromodulation Society (NANS) Annual Meeting, it is essential for investors to consider the implications of its innovations within the market landscape.

Integer's focus on miniaturization is particularly noteworthy, as it represents a growing trend in medical device technology that aims to enhance patient outcomes while driving down development costs. The company's emphasis on accelerated development timelines and risk mitigation is likely to resonate with medical device companies seeking to bring novel therapies to market. As a partner to these entities, Integer not only enhances its market positioning but potentially increases its revenue through long-term contracts and collaborations.

Furthermore, the introduction of its Xcellion® Gen 3 Fast Charge Lithium Ion battery technology is a critical competitive advantage. The promise of best-in-class runtime and rapid recharge capabilities can significantly influence the adoption of Integer’s devices, making them more appealing to healthcare providers and patients alike. This innovation highlights Integer's commitment to improving the operational efficiency of medical devices, which is uniquely attractive in the increasingly competitive medtech market.

Financially, investors should monitor Integer’s ability to capitalize on these trends. With an established reputation in the contract development and manufacturing sector, potential growth in the neuromodulation and AIMD arenas could translate into improved earnings results. As Integer showcases its advancements at the NANS meeting, it will be crucial for stakeholders to track contractual agreements and adoption rates of their technologies, as these will be indicators of future financial performance. In conclusion, Integer holds promise as a strong player in the medical device sector, with innovative solutions that could drive growth in the coming years.